Dafna Capital Management LLC Nurix Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$8.7 - $13.28 $87,000 - $132,800
-10,000 Reduced 1.76%
556,695 $5.56 Million
Q2 2022

Aug 15, 2022
BUY
$7.88 - $14.82 $184,005 - $346,061
23,351 Added 4.3%
566,695 $7.18 Million
Q1 2022

May 16, 2022
BUY
$12.94 - $29.65 $3.07 Million - $7.03 Million
237,024 Added 77.38%
543,344 $7.61 Million
Q1 2021

May 17, 2021
BUY
$26.98 - $50.17 $8.26 Million - $15.4 Million
306,320 New
306,320 $9.52 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $923M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email